Multidimensional Frailty Assessment and Post-Transplant Outcomes in Liver Transplant Candidates
Recruiting
Observational Study
End-Stage Liver Disease
Liver Transplantation
Cirrhosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Study type
- Observational
- Participants needed
- 60 (estimated)
- Sponsor
- Izmir Bakircay University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study will evaluate frailty, nutrition, sarcopenia, and psychological health in people waiting for a liver transplant. The purpose is to understand how these factors affect outcomes before and after transplantation. By identifying patients at higher risk early, the study aims to support the development of better care programs in the future.
Participants will complete simple tests of physical…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Being listed as a liver transplant candidate
* Age between 18 and 65 years
* Ability to understand the Turkish language
Exclusion Criteria:
* Presence of orthopedic and/or neurological problems severe enough to prevent completion of assessment tools
* Inability to understand…
Contacts